# Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula

> **NCT02425423** · PHASE3 · COMPLETED · sponsor: **United Pharmaceuticals** · enrollment: 100 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DIETARY_SUPPLEMENT:** New thickened formula

## Key facts

- **NCT ID:** NCT02425423
- **Lead sponsor:** United Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02425423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02425423, "Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02425423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*